Clinical trials: Cyclic Vomiting Syndrome

Nausea and Vomitting

A Study of TAK-951 in Participants With Cyclic Vomiting Syndrome (CVS)

• Terminated
• Age: 18 to 50 years
• Phase 1
• Results posted

This is a study of TAK-951 in participants with cyclic vomiting syndrome (CVS). The main aims of this study are as follows: To check for side effects from treatment with TAK-951.

Trial name

NCT06768658

Testing

TAK-951

Where

United States

Volunteers

1 people

Sponsor

Takeda